Drug Discovery World

MARCH 29, 2023

Julian Collins, Jana Windt and Michiel Stork, ProBioGen Julian Collins has been appointed as Senior Vice President, Head of People & Organizational Development (P&OD) and a member of the Executive Team. In 2022, he was awarded a Commander of the Order of the British Empire (CBE) for services to UK Life Science.

Life Science 52

Life Science DNA Business Development Drugs 52

Drug Discovery World

APRIL 27, 2023

Megan Thomas takes a snapshot of the US biotech market and some of the ongoing research coming out of the US. In 2021, Savills put together a report on the regional hubs attracting science/pharma investment 1. The Boston Globe headline 3 , ‘Life sciences is poised to be Boston’s dominant industry.

Life Science 52

Life Science Drugs Research Gene Splicing 52

pharmaphorum

NOVEMBER 17, 2020

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. Improving the design of commercial research by listening to the patient voice. Gaining patient input on marketing and recruitment materials.

Clinical Trials 116

Clinical Trials Clinical Trials Trials Life Science 116

Drug Discovery World

MARCH 13, 2024

With government support and strong academic institutions, does Singapore have what it takes to become a global centre for life sciences? DDW’s Diana Spencer explores how the country is turning pioneering science into a successful biotech industry. UK-based molecular diagnostics group Yourgene operates in Singapore.

Life Science 69

Life Science Genome Genomics Research 69

pharmaphorum

FEBRUARY 2, 2021

This pharmaphorum webinar, held in association with the National Institute for Health Research (NIHR), will take place on Thursday 25 th March at 15:30 GMT / 16:30 CET and look at where virtual trials fit into the next generation of pharmaceutical clinical research.

Clinical Research 71

Clinical Research Trials Research Clinical Trials 71

Drug Discovery World

SEPTEMBER 5, 2023

Eric Hardter, Associate Director, Regulatory Affairs, Boyds With over eight years of regulatory experience, Hardter joins Boyds from global contract research organisation, The Emmes Company, where he led the regulatory strategy department. He joins SiSaf from Metanomics where he designed the company’s economy simulation algorithm.

Drugs 59

Drugs Business Development Life Science Development 59

The Pharma Data

JANUARY 24, 2021

With this acquisition, Calibre Scientific bolsters its strength in the chromatography market and continues to broaden its life sciences presence in Europe. Headquartered in Paris, France, AIT supplies public and private researchers and pharmaceutical laboratories. About Calibre Scientific. Source link.

Life Science 52

Life Science Reagent Manufacturing Production 52

Drug Discovery World

JANUARY 23, 2024

The annual Genesis conference took place at the end of 2023 in London, bringing together key opinion leaders, investors and innovators from across the life sciences sector to exchange insights, debate trends and generate deals. What would Alexandra Gray like from the life sciences industry?

Life Science 59

Life Science Business Development Protein Development 59

Drug Discovery World

FEBRUARY 12, 2024

In 2024, we can expect another wave of innovative new drugs to be developed using the technology, given that the AI-fuelled small molecule discovery pipeline is growing by almost 40% annually.” Fiona Maini, Senior Director Global Compliance and Strategy at Medidata “AI is dominating conversations across the drug discovery process.

Genome 139

Genome Genomics Life Science Gene Therapy 139

pharmaphorum

FEBRUARY 1, 2022

Attendees will learn more about how an SCA was used at the design and execution phases in a recent study of new treatments for relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) and will also receive an eBook ‘How to harness the potential of AI and real-world data for clinical research’. About the panel.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Engineer 104

Drug Discovery World

DECEMBER 20, 2022

BII is an international enterprise foundation with a non-profit objective of incubating and accelerating world-class life science research. Its Bio Studio program aims to foster the creation of new life science start-ups based on research from world-class scientists to benefit people and society.

Protein 52

Protein Life Science Antibody Business Development 52

ACRP blog

APRIL 30, 2024

Staffing and retention have been the top concern at research sites since 2020, with patient recruitment and enrollment ranking second, and the complexity of clinical trials ranking third, based on WCG survey data for 2020 to 2023. based clinical research sites. Initially, a lack of resources was exacerbated by the pandemic.

Clinical Research 59

Clinical Research Clinical Trials Clinical Trials Clinical Research Coordinator 59

XTalks

APRIL 21, 2023

Life science startups face unique challenges given the highly regulated and complex nature of the industry. Here are some lessons that entrepreneurs in this space can learn from past successes and failures: Prioritize ethics and integrity: The Theranos case highlights the importance of maintaining ethical standards in business.

Life Science 98

Life Science Trials Production Compliance 98

Cloudbyz

SEPTEMBER 16, 2021

Cloudbyz, a fast-growing integrated Clinical Research and development solution provider in Healthcare & Life Science, has recently executed a CSR drive at the Samarthanam Trust for the Disabled showcasing its commitment to social responsibility by giving back to the community. About the Cloudbyz.

Life Science 52

Life Science Development Clinical Trials Clinical Trials 52

ACRP blog

MAY 5, 2024

Some of the other educational sessions from the Saturday morning lineup of topics concentrated on the intricacies of pitching the availability of clinical trials to potential participants, and on incorporating the principles of best patient engagement practices into the training of clinical research professionals. this morning (May 4).

Clinical Research 59

Clinical Research Clinical Research Coordinator Clinical Trials Clinical Trials 59

Drug Discovery World

APRIL 25, 2023

DDW takes a look at some key global activity taking place around the world for drug discovery and life sciences start-ups. In life sciences these innovative companies are creating the medicines and technologies that will change and improve our lives in years to come, and laying the foundations for the industries of the future.”

Life Science 52

Life Science Drugs Development Research 52

pharmaphorum

JANUARY 6, 2023

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences teams to collaborate efficiently and effectively in 2023. She is responsible for product strategy, customer engagement, and business development.

Life Science 111

Life Science Development Research Production 111

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. While some patient groups are set up to work with industry, there are some who are more reticent about linking with pharma.

Clinical Trials 101

Clinical Trials Clinical Trials Trials Clinical Research 101

pharmaphorum

JANUARY 12, 2023

The life sciences unit of Google parent Alphabet – which raised $1 billion back in September to fund its precision health agenda and business development activities, including possible acquisitions – said the move would allow it to streamline its operations.

Drug Delivery 69

Drug Delivery Life Science Production Engineer 69

pharmaphorum

SEPTEMBER 13, 2022

It’s all change at Alphabet’s life sciences business Verily, with a $1 billion funding round and a shake-up of its senior leadership, including a new chief executive and executive chairman, who will have to decide how to spend the new money. Verily’s Andrew Conrad.

Life Science 75

Life Science Development Clinical Trials Clinical Trials 75

pharmaphorum

APRIL 14, 2022

Benefits of attending: •Listen to case studies presenting on pre-clinical and clinical research in areas such as oncology and what can be learned for future clinical trials. Managing CMC Activities For The Development Of Oligonucleotide Therapeutics led by Mia Kiistala, CEO/Owner/Principal Consultant, Aurora CMC Consulting.

RNA 52

RNA Clinical Trials Clinical Trials Life Science 52

Pharmaceutical Technology

DECEMBER 22, 2022

Financing recognises companies and institutions that have raised significant capital during the research period whether it be through corporate finance, the capital markets or fund raising. What all the ranked entities have in common is the demonstration of new concepts not just within their own business but in the sector as a whole.

Insulin 130

Insulin Production Development Genetics 130

pharmaphorum

FEBRUARY 11, 2022

Komodo Health’s president and co-founder, Web Sun, tells us about his company’s new partnership with the Chan Zuckerberg Initiative (CZI) to improve early diagnosis and advance research of rare diseases by providing CZI’s Rare as One Network healthcare data and software. About the author.

Life Science 105

Life Science Engineer Development Big Data 105

pharmaphorum

OCTOBER 12, 2022

Genomic medicine is a rapidly growing space in which researchers use the information in a person’s genes to identify and administer medical treatment.”. Genomic medicine is a rapidly growing space in which researchers use the information in a person’s genes to identify and administer medical treatment.

Genome 105

Genome Genomics Medicine Development 105

XTalks

MAY 17, 2024

Prior to joining Calliditas Therapeutics as CMO, he held roles at GlaxoSmithKline (GSK) and Takeda, focusing on clinical and business development in rare diseases. I’ve had a great passion for drug development in rare diseases,” says Dr. Philipson, underscoring a commitment that would shape his career’s trajectory.

Development 52

Development Drugs Clinical Trials Clinical Trials 52

pharmaphorum

DECEMBER 9, 2021

After making her way from early-stage drug development research to her current role, Heather got straight to work on creating sustainable collaborations that made life better for people and their families. “I Having a real impact on consumers.

Allergies 105

Allergies Life Science Development Scientist 105

Drug Discovery World

JUNE 5, 2023

New approaches to partnering In this event in the Biotech track, Clive Cookson, Science Editor at the Financial Times, interviewed John McDonald, Corporate Vice President, Global R&D Business Development, Novo Nordisk. The discussion answered three main questions: What is the new direction for the company?

Genome 52

Genome Genomics Life Science Genetics 52

pharmaphorum

APRIL 25, 2022

Aaron Gani, founder and CEO of BehaVR, and Krys Zaluski, director of business development, digital health at Sumitomo Dainippon Pharma, discuss their groundbreaking partnership to develop and commercialise digital therapeutics (DTx) products. . We just hadn’t found each other. About the author .

Behavioural Health 105

Behavioural Health Production Clinical Trials Clinical Trials 105

Drug Discovery World

JUNE 29, 2023

Nick Foster, Vice President, Discovery CRO, Cresset Foster joins Cresset from Metrion Biosciences, where he served as Chief Commercial Officer and Head of Business Development. He has previously held senior leadership positions with WuXi AppTec and Optibrium. He joins Metrion from Pfizer where he was Senior Director.

Drugs 52

Drugs Gene Therapy Development Clinical Trials 52

The Pharma Data

DECEMBER 17, 2020

He previously spent more than a decade at Medtronic in the company ’ s Minimally Invasive Therapies Group where he served as the global vice president and General Manager of General Surgery, and in various roles working on research, development, and strategy. He spent 27 years at Merck & Co. Immune Regulation – U.K.-based

Development 52

Development Gene Therapy Engineer Life Science 52

pharmaphorum

JANUARY 26, 2021

No more ‘business as usual’ for pharma’s customer engagement. Life sciences companies need to rethink their customer engagement paradigms in light of changing customer preferences. We’re starting to see this happen through the emergence of smart homes and smart cars (i.e., About Healthware Group.

Clinical Trials 141

Clinical Trials Clinical Trials Sales Life Science 141

pharmaphorum

MAY 30, 2022

AppliedVR and Komodo Health will perform several health economic outcome research studies using a method Sackman says will allow the companies to shape the trials’ speed, quality, and design. Researchers will also evaluate the physical function, both subjective, through the traditional pain scores and patient-reported outcomes.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Big Data 97

The Pharma Data

NOVEMBER 5, 2020

Horizon Therapeutics – Karin Rosén joined Ireland-based Horizon Therapeutics as executive vice president, research and development and chief scientific officer. Taveras will lead all research and non-clinical development functions supporting the company’s pipeline of investigational therapies.

Genome 40

Genome Genomics Medicine Life Science 40

The Pharma Data

DECEMBER 20, 2020

A cross-border team of Baker McKenzie life sciences lawyers led by Julia Braun advised Allecra Therapeutics on the legal aspects of the licensing. Staatz Business Development & Strategy acted as corporate finance and transaction adviser on the deal.

Licensing 40

Licensing Licensing Life Science Manufacturing 40

pharmaphorum

DECEMBER 14, 2022

As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in digital health and life sciences companies that drive healthcare innovation and improve patient experiences. It aims to shape companies in the digital healthcare, connected medical devices, and life sciences spaces.

Life Science 105

Life Science Development Business Development Genetics 105

Delveinsight

SEPTEMBER 8, 2021

Business Consultants can sometimes be observed as a catalyst for change in the company’s regular path of operation. In pharmacology, consultancy can be provided to assist client organizations in biotechnology, life science , and other healthcare-related fields. They also offer companies the ability to overcome challenges.

Production 52

Production Marketing Pharma Companies Development 52

Drug Discovery World

APRIL 29, 2024

Bill Dawson, Chair, Medicines Manufacturing Industry Partnership (MMIP): Dawson is Head of Biologics and Devices Manufacturing at GSK and has over 25 years’ experience in the vaccines, biopharma, pharmaceutical and clinical research (CRO) industries.

Drugs 52

Drugs Sales Gene Therapy Life Science 52